Renee Maria Saliby

All papers authored by Renee Maria Saliby

This paper is made freely available by the publisher.

2024 Renée M. Saliby

, Eddy Saad

, Soki Kashima

, David A. Schoenfeld, David A. Braun

Update on Biomarkers in Renal Cell Carcinoma

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2023 Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan

, Shahabbedin Sotudian

, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu

, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby

, Ziwei Zhang and 28 other authors

Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping

Upload

Kevin Hakimi

, Ava Saidian

, Justine Panian, Pedro Barata

, Stephanie Berg, Steven L. Chang

, Renee M. Saliby

, Hannah Dzimitrowicz

, Hamid Emamekhoo, Evan Gross, Deepak Kilari, Elaine Lam

, Mimi Nguyen, Margaret Meagher, Luke Wang and 9 other authors

Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis

Upload

Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan

, Shahabbedin Sotudian

, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu

, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby

, Ziwei Zhang and 28 other authors

Liquid biopsy epigenomic profiling for cancer subtyping

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

, Wanling Xie, Ronan Flippot, Thomas Denize, M. Harry Kane, Katrine N. Madsen, Miriam Ficial, Laure Hirsch, Xiao X. Wei, John A. Steinharter, Lauren C. Harshman, Ulka N. Vaishampayan and 10 other authors

Figure S2 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S9 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S7 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S6 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S3 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S8 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Table S3 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S11 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S10 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S5 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Data from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Supplementary Data from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S12 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Table S2 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S1 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Renee Maria Saliby

, Talal El Zarif, Ziad Bakouny, Valisha Shah

Figure S4 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Renee Maria Saliby